Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

1.

Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications.

Motivala AA, Tamhane U, Saab F, Li J, Rogers EK, Froehlich J, Moscucci M, Eagle KA, Gurm HS.

Am J Cardiol. 2007 Nov 1;100(9):1359-63. Epub 2007 Aug 16.

PMID:
17950790
[PubMed - indexed for MEDLINE]
2.

Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.

Kwa AT, Rogers JH.

J Interv Cardiol. 2008 Apr;21(2):107-17. doi: 10.1111/j.1540-8183.2007.00335.x. Epub 2008 Jan 30. Review.

PMID:
18248357
[PubMed - indexed for MEDLINE]
3.

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ; ACUITY Investigators.

JAMA. 2007 Dec 5;298(21):2497-506.

PMID:
18056903
[PubMed - indexed for MEDLINE]
4.

Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.

Elbarouni B, Elmanfud O, Yan RT, Fox KA, Kornder JM, Rose B, Spencer FA, Welsh RC, Wong GC, Goodman SG, Yan AT.

Am Heart J. 2010 Sep;160(3):420-7. doi: 10.1016/j.ahj.2010.05.036.

PMID:
20826248
[PubMed - indexed for MEDLINE]
5.

Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, Mehran R.

J Am Coll Cardiol. 2009 Sep 29;54(14):1293-302. doi: 10.1016/j.jacc.2009.07.019.

PMID:
19778672
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice.

Heer T, Juenger C, Gitt AK, Bauer T, Towae F, Zahn R, Senges J, Zeymer U; Acute Coronary Syndromes (ACOS) Registry Investigators.

J Thromb Thrombolysis. 2009 Oct;28(3):325-32. doi: 10.1007/s11239-008-0294-y. Epub 2008 Dec 20.

PMID:
19101783
[PubMed - indexed for MEDLINE]
7.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
[PubMed - indexed for MEDLINE]
8.

Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY.

Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18.

PMID:
18641090
[PubMed - indexed for MEDLINE]
9.

Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.

Chew DP, Huang Z, Pieper KS, White H, Mahaffey KW, Ferguson JJ, Califf RM, Aylward PG.

Am Heart J. 2008 Feb;155(2):239-44. doi: 10.1016/j.ahj.2007.10.002. Epub 2007 Nov 26.

PMID:
18215592
[PubMed - indexed for MEDLINE]
10.

[Bleeding complications after treatment with clopidogrel and acetylsalicylic acid after acute coronary syndrome].

Kjaer J, Larsen CH, Poulsen TS, Møller JE, Mickley H.

Ugeskr Laeger. 2006 Sep 18;168(38):3209-14. Danish.

PMID:
17026894
[PubMed - indexed for MEDLINE]
11.

Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.

Ferguson JJ, Wilson JM, Diez J.

Minerva Cardioangiol. 2007 Oct;55(5):529-56. Review.

PMID:
17912162
[PubMed - indexed for MEDLINE]
12.
13.

Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.

Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, DeYoung JP, Rose B, Grondin FR, Gallo R, Gore JM, Yan AT; Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators.

Am Heart J. 2009 Apr;157(4):642-50.e1. doi: 10.1016/j.ahj.2009.01.002.

PMID:
19332190
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.

Cortese B, Micheli A, Picchi A, Bandinelli L, Brizi MG, Severi S, Limbruno U.

Coron Artery Dis. 2009 Aug;20(5):348-53. doi: 10.1097/MCA.0b013e32832cff08.

PMID:
19543084
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of bivalirudin in acute coronary syndromes.

Hartmann F.

Curr Pharm Des. 2008;14(12):1191-6. Review.

PMID:
18473866
[PubMed - indexed for MEDLINE]
16.

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.

Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E.

J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.

PMID:
18498956
[PubMed - indexed for MEDLINE]
Free Article
17.

Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.

Wang TY, Robinson LA, Ou FS, Roe MT, Ohman EM, Gibler WB, Smith SC Jr, Peterson ED, Becker RC.

Am Heart J. 2008 Feb;155(2):361-8. doi: 10.1016/j.ahj.2007.09.003. Epub 2007 Oct 25.

PMID:
18215609
[PubMed - indexed for MEDLINE]
18.

The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.

O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD.

J Am Coll Cardiol. 2009 Aug 18;54(8):678-85. doi: 10.1016/j.jacc.2009.05.025.

PMID:
19679245
[PubMed - indexed for MEDLINE]
Free Article
19.

Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW, Ware JH, Lincoff AM, Stone GW.

J Am Coll Cardiol. 2009 May 26;53(21):1965-72. doi: 10.1016/j.jacc.2009.03.006.

PMID:
19460609
[PubMed - indexed for MEDLINE]
Free Article
20.

Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW.

J Am Coll Cardiol. 2008 Sep 2;52(10):807-14. doi: 10.1016/j.jacc.2008.05.036.

PMID:
18755342
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk